Trial NCT04942405
Publication Tanriover M, Vaccines, 2022
Primary outcome on the report: Protection rates of two doses of TURKOVAC and two doses of CoronaVac against RT-PCR-confirmed symptomatic COVID-19 at least 14 days after the second vaccination dose.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.